This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Ajou University Industry-Academic Cooperation Foundation, Standigm Inc. Active years: 2018-2026.
Company Filing History:
3 out of 380 
1 out of 3 Years Active: 2018-2026
Title: Yu Ree Choi: Innovator in Synucleinopathy Treatments
Introduction
Yu Ree Choi is a prominent inventor based in Suwon, South Korea. He has made significant contributions to the field of medical research, particularly in the treatment of synucleinopathies. With a total of 3 patents, his work focuses on innovative compositions aimed at preventing and treating neurodegenerative diseases.
Latest Patents
One of Yu Ree Choi's latest patents is a composition for treating synucleinopathies. This composition includes efavirenz or a salt or solvate thereof, along with a pharmaceutically acceptable carrier. It is designed to prevent or treat conditions such as Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. The composition works by hindering cell-to-cell transmission of alpha-synuclein, preventing intracellular aggregation of α-synuclein, and inhibiting the transmission of aggregated α-synuclein.
Another notable patent involves a pharmaceutical composition comprising an expression or activity inhibitor of c-src for preventing or treating synucleinopathy. This composition includes a substance that inhibits the expression or activity of c-src, which is crucial in inhibiting the aggregation and migration of α-synuclein. This innovative approach aims to mitigate the cytotoxic effects of α-synuclein on adjacent cells and can serve as a therapeutic agent for synucleinopathy.
Career Highlights
Yu Ree Choi has worked with notable institutions, including the Ajou University Industry-Academic Cooperation Foundation and Standigm Inc. His experience in these organizations has allowed him to advance his research and contribute to the development of effective treatments for neurodegenerative diseases.
Collaborations
Throughout his career, Yu Ree Choi has collaborated with esteemed colleagues such as Sang Myun Park and Jae Bong Kim. These partnerships have fostered a collaborative environment that enhances the innovation process in his research.
Conclusion
Yu Ree Choi is a dedicated inventor whose work in the field of synucleinopathy treatments is paving the way for new therapeutic options. His innovative compositions and collaborations highlight his commitment to advancing medical science and improving patient outcomes.